Skip to content
Search

Latest Stories

Pregabalin caused over 40 per cent of all drug related deaths in Northern Ireland

Deaths involving pregabalin have climbed sharply in Northern Ireland during 2019, accounting for 40.3 per cent of all drug related deaths, latest official figures showed on Tuesday (March 2).

The annual number of deaths involving this controlled substance rose from nine in 2016 to 54 in 2018 to 77 in 2019.


Since 2010, over half of drug-related deaths each year have involved an opioid. In 2019, 128 drug-related deaths had an opioid mentioned on the death certificate.

Heroin and morphine were the most frequently mentioned opioids in 2019, connected to 46 drug-related deaths, up from 40 in 2018 and the highest number on record.

Drug-related deaths involving cocaine increased from 28 in 2018 to 37 in 2019, the highest level on record.

Diazepam was listed in 36.6 per cent of all drug-related deaths in 2019, a decrease from previous years.

The proportion of all drug-related deaths that also mentioned alcohol on the death certificate decreased from 23.3 per cent in 2018 to 16.2 per cent in 2019.

The statistics also indicate that there are notably higher numbers of drug-related deaths in areas of deprivation across Northern Ireland.

People living in the most deprived areas are five times more likely to die from a drug-related death than those in the least deprived areas.

"First and foremost we must always remember that these deaths are not just statistics. They are people who will be sorely missed and I would like to offer my sincere condolences to all their loved ones," NI Health Minister Robin Swann said.

Outlining work being undertaken by his department to prevent drug related deaths, Swann added: "My Department is overseeing the development a new alcohol and drug strategy for Northern Ireland aimed at preventing and addressing the harms related to all substance use. A consultation process on the draft Strategy has recently completed and work has now begun on analysing responses. Once this is complete my officials will work with key stakeholders, including service users and their families to finalise the strategy.”

There were 191 drug-related deaths registered in Northern Ireland in 2019, the highest number recorded since the time series began in 1997. Almost half (45.5 per cent) of these deaths were of men aged 25-44.

The total number of drug related deaths is more than double that recorded a decade ago (84) but is similar to the total of 189 in 2018.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less